Rabeprazole and Domperidone SR Tablets
RABISE-DSR Tablets contain 20 mg of Rabeprazole and 30 mg of Domperidone. This combination belongs to the gastrointestinal and gastro-care segment, and it is used under medical supervision for conditions related to excess stomach acid and related symptoms. Godase Healthcare offers RABISE-DSR tablet in 10 x 10 Alu-Alu tablet packaging, which makes it a suitable option for partners who are looking to expand their PCD pharma product range.
For PCD Pharma Franchise partners, distributors, wholesalers, medical representatives, and pharma entrepreneurs, RABISE-DSR can be added to a gastro-care and acid-peptic product portfolio.
Product Highlights:
- Brand Name: RABISE-DSR
- Composition: Rabeprazole 20 mg + Domperidone 30 mg SR
- Dosage Form: Sustained-Release Tablets
- Therapeutic Segment: Gastrointestinal / Gastroenterology
- Product Category: PPI + Prokinetic Combination
- Target Partners: PCD Pharma Franchise Partners, Distributors, Wholesalers & Pharma Entrepreneurs
- Manufacturer/Marketer: Godase Healthcare
PCD Pharma Franchise for Rabeprazole and Domperidone Tablets – Godase Healthcare
Godase Healthcare offers Rabeprazole and Domperidone tablets under its own brand RABISE-DSR for businesses that are looking to expand their gastrointestinal and gastro-care product portfolio. This combination can be considered by pharma businesses that want to add an established gastro-care formulation to their existing range. This tablet is highly suitable for PCD pharma franchise partners, distributors, wholesalers, and entrepreneurs who are looking to build or expand their pharma product range.
Interested partners can contact Godase Healthcare to discuss product availability, pricing, minimum order requirements, territory availability, supply, promotional support, and other PCD business terms.
Why Add RABISE-DSR Tablet?
For PCD pharma partners and distributors, having products from different therapeutic segment can help to build a stronger product range. RABISE-DSR can be added to a gastrointestinal and gastro-care portfolio.
- Gastro-Care Product: Adds a gastrointestinal medicine to your existing pharma range.
- Dual-Ingredient Combination: Contains Rabeprazole 20 mg + Domperidone 30 mg SR in one tablet.
- Portfolio Expansion: Suitable for partners looking to expand their gastroenterology product range.
- Established Segment: Rabeprazole + Domperidone is a well-known combination in the gastrointestinal pharmaceutical segment.
Disclaimer: RABISE-DSR is a prescription pharmaceutical tablet. The information on this page is for educational and business purposes only, and it is not medical advice. Use this product only under the guidance of a doctor.
